Atlas Trials

Cabozantinib in Patients With Hepatocellular Carcinoma (ACTION)

Clinical trial NCT04316182 · COMPLETED

Trial details

NCT number
NCT04316182
Sponsor
Fundacion Clinic per a la Recerca Biomédica
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2020-07-31
Primary completion
2023-02-22
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.